WO2020082806A1 - 基于样本处理的病种确定方法、装置及终端 - Google Patents
基于样本处理的病种确定方法、装置及终端 Download PDFInfo
- Publication number
- WO2020082806A1 WO2020082806A1 PCT/CN2019/095049 CN2019095049W WO2020082806A1 WO 2020082806 A1 WO2020082806 A1 WO 2020082806A1 CN 2019095049 W CN2019095049 W CN 2019095049W WO 2020082806 A1 WO2020082806 A1 WO 2020082806A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment plan
- patient
- target
- sample
- treatment
- Prior art date
Links
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Definitions
- the present application relates to the field of computer technology, and in particular to a method, device and terminal for determining a disease type based on sample processing.
- Clinical path refers to the establishment of a set of standardized treatment models and treatment procedures for a certain disease. It is a comprehensive model related to clinical treatment. After adopting the clinical pathway as the standard treatment plan for a certain disease, not only can the patient be prevented from receiving unnecessary treatment items, but also the disease can be determined by finding the clinical pathway closest to the actual treatment plan for treating the patient.
- the common treatment plan for a disease in different regions may be significantly different from the clinical path corresponding to the disease. This makes the accuracy of determining the type of disease a patient suffers based on a clinical path low.
- the embodiments of the present application provide a method for determining a disease type based on sample processing, which can improve the accuracy of the result of determining the disease type of a patient.
- an embodiment of the present application provides a method for determining a disease type based on sample processing, the method includes:
- the first treatment plan is determined as a target standard treatment plan, and the target standard treatment plan is corresponding to the preset area and the target disease type Standard treatment plan, the target standard treatment plan includes at least one standard treatment item for treating the target disease within the preset area;
- the disease type of the patient to be detected in the preset area is determined according to the target standard treatment plan.
- an embodiment of the present application provides a disease determination apparatus based on sample processing, the apparatus includes:
- An obtaining module configured to obtain at least one treatment plan of at least one sample patient in a preset area, where the sample patients have the same target disease type;
- a determining module configured to determine, from the at least one treatment plan, a first treatment plan matching the clinical path corresponding to the target disease type
- a calculation module configured to calculate the utilization rate of the first treatment plan according to the number of patients in the first sample corresponding to the first treatment plan, the first sample patients are treated by using the first treatment plan At least one sample patient;
- the determining module is further configured to determine the first treatment plan as a target standard treatment plan if the utilization rate of the first treatment plan is greater than a preset threshold, and the target standard treatment plan is the same as the preset A standard treatment plan corresponding to the area and the target disease type, and the target standard treatment plan includes at least one standard treatment item for treating the target disease type in the preset area;
- the determining module is further configured to determine the disease type of the patient to be detected in the preset area according to the target standard treatment plan.
- an embodiment of the present application provides a terminal.
- the terminal includes a processor, an input device, an output device, and a memory.
- the processor, input device, output device, and memory are connected to each other.
- the computer program includes program instructions, and the processor is configured to call the program instructions to perform the method of the first aspect.
- a computer-readable storage medium stores a computer program, and the computer program includes program instructions, which when executed by a processor causes the processing Implement the method described in the first aspect.
- different target standard treatment schemes can be established for different regions, and then a target standard treatment scheme matching the actual treatment scheme of the patient can be found to determine the disease type of the patient, which can improve the determination result of the disease type of the patient Accuracy.
- FIG. 1 is a schematic flowchart of a method for determining a disease type based on sample processing provided by an embodiment of the present application
- FIG. 2 is a schematic flowchart of another method for determining a disease type based on sample processing according to an embodiment of the present application
- FIG. 3 is a schematic structural diagram of a disease determination apparatus based on sample processing provided by an embodiment of the present application
- FIG. 4 is a schematic structural diagram of a terminal provided by an embodiment of the present application.
- the image retrieval method provided in the embodiment of the present application is implemented in a terminal, and the terminal includes electronic devices such as a smart phone, a tablet computer, a digital audio and video player, an e-reader, a handheld game machine, or an in-vehicle electronic device.
- the terminal includes electronic devices such as a smart phone, a tablet computer, a digital audio and video player, an e-reader, a handheld game machine, or an in-vehicle electronic device.
- FIG. 1 is a schematic flowchart of a method for determining a disease type based on sample processing in an embodiment of the present application. As shown in the figure, the flow of the method for determining a disease based on sample processing in this embodiment may include:
- the terminal acquires at least one treatment plan of at least one sample patient in a preset area, where the sample patients have the same target disease type.
- the preset area may be an area composed of one or more cities, districts, and counties, for example, the preset area is Yubei District, Yuzhong District, Wushan County, and the like.
- the sample patients suffer from the same target disease.
- the target disease can be appendicitis, cholecystitis, gallstones and other single diseases.
- the treatment plan is a collection of treatment items received by the sample patient.
- the treatment items may include blood drawing, CT, taking medicine, hospitalization, etc., because the treatment plans adopted by different doctors for the target disease in the preset area may be different, so The terminal can obtain different treatment plans for the same target disease.
- the terminal may also select a sample patient from patients with target diseases in the preset area according to a preset screening rule.
- the screening rules can be set to screen out the patients whose hospitalization duration is the regular hospitalization duration. For example, if the patient with the target disease has a conventional hospitalization duration of 5 to 10 days, the terminal will set the hospitalization duration between 5 to A 10-day patient is determined to be a sample patient. Further, the terminal can also randomly select a preset number of patients from the patients whose hospital stay is between 5 and 10 days as the sample patient.
- the terminal may also combine the variance of the length of hospitalization of at least one patient in the preset area to screen the sample. Specifically, the terminal obtains the hospitalization of at least one patient with the target disease in the preset area Duration, detecting whether the variance of the hospitalization length of at least one patient with the target disease in the preset area is less than the preset variance, if the variance is less than the preset variance, the terminal One patient is identified as the sample patient.
- the variance calculation formula is:
- s 2 represents the variance
- x n represents the length of hospitalization of the nth patient
- M represents the average length of hospitalization of each patient
- the terminal calculates that the variance of the length of hospitalization of each patient is 0.4, then it is determined that the variance is less than the preset variance, and the terminal determines each patient with the target disease in the preset area as the sample patient.
- the variance of the length of hospitalization of at least one patient with the target disease in the preset area is greater than or equal to the preset variance, the patient corresponding to the length of hospitalization that causes the variance to be too large needs to be screened out, specifically
- the screening method may be to calculate the difference between each hospitalization duration and the average hospitalization duration, and screen out the patients corresponding to the hospitalization duration with the largest difference one by one until the variance of the hospitalization duration of the remaining patients is less than the preset variance.
- the hospitalization duration of each patient with the target disease in the preset area is 1, 5, 6, 6, 6, 7, 11 (days), the preset variance is 2, and the calculated variance is 8.7, then the terminal
- the hospitalization duration of each patient obtained by screening the patients corresponding to the hospitalization duration with excessive variance is 5, 6, 6, 6, 7 (days), and the terminal will determine the patients corresponding to each hospitalization duration remaining after screening It is a sample patient.
- the terminal After acquiring at least one sample patient with a target disease in the preset area, the terminal will acquire at least one treatment plan for at least one sample patient in the preset area, where the sample patients have the same target disease.
- the terminal determines a first treatment plan matching the clinical path corresponding to the target disease type from at least one treatment plan.
- the terminal determines a first treatment plan matching the clinical path corresponding to the target disease type from the at least one treatment plan.
- the specific determination method of the first treatment plan may be that the terminal separately calculates the similarity of the clinical path corresponding to each treatment plan in the at least one treatment plan and the target disease type, where the similarity is determined by the treatment plan and the target disease type The number of identical treatment items in the corresponding clinical pathway is determined.
- the specific calculation method of the similarity may be that the terminal obtains the number of the same treatment items in the clinical path corresponding to the treatment plan and the target disease type, and obtains the total number of treatment items in the treatment plan, and the terminal sets the same treatment item
- the ratio of the number of and the total number is determined as the similarity of the clinical path corresponding to the treatment plan and the target disease type.
- at least one treatment plan for at least one sample patient in the preset area includes treatment plan 1, treatment plan 2, and treatment plan 3.
- the treatment programs included in the treatment plan and the clinical path corresponding to the target disease are shown in Table 1:
- treatment items can include blood drawing, CT, taking medicine, hospitalization, etc. Different letters are used to indicate different treatment items, as can be seen from Table 1, the terminal calculates treatment plan 1, treatment plan 2, treatment plan 3 and target disease The similarities of the corresponding clinical pathways are 75%, 50%, and 50%, respectively.
- the treatment plan with the highest degree of similarity in the clinical path corresponding to the target disease in the at least one treatment plan may be determined It is the first treatment plan.
- the terminal can determine the treatment plan 1 as the first treatment plan.
- the terminal calculates the utilization rate of the first treatment plan according to the number of patients in the first sample corresponding to the first treatment plan.
- the terminal after determining the first treatment plan, the terminal will calculate the utilization rate of the first treatment plan according to the number of first sample patients corresponding to the first treatment plan, where the first sample patient adopts the first treatment At least one sample patient to be treated by the protocol.
- the terminal may obtain the number of first sample patients corresponding to the first treatment plan, and calculate the ratio of the number of first sample patients to the number of at least one sample patient in the preset area, and the terminal will calculate the calculated ratio Determine the utilization rate of the first treatment plan. For example, if the number of first sample patients is 100 and the number of at least one sample patient in the preset area is 200, the terminal determines that the utilization rate of the first treatment plan is 50%.
- the terminal determines the first treatment plan as the target standard treatment plan.
- the target standard treatment plan is a standard treatment plan corresponding to the preset area and the target disease, that is, the standard treatment plan used to treat the target disease in the preset area, and the target standard treatment plan includes At least one standard treatment item for treating the target disease in the preset area.
- the terminal After obtaining the usage rate of the first treatment plan, the terminal determines whether the usage rate is greater than a preset threshold. If the usage rate is greater than the preset threshold, the terminal determines the first treatment plan as the target standard treatment plan.
- the preset threshold may be 50%, 60%, etc., which may be set in advance by the R & D personnel, which is not limited in the embodiments of the present application.
- the terminal determines the disease type of the patient to be detected in the preset area according to the target standard treatment plan.
- the patient to be tested may be a patient undergoing treatment in a preset area.
- the disease type of the patient to be tested in the preset area will be determined according to the target standard treatment plan.
- the terminal obtains the treatment plan for the patient to be tested, and detects the similarity between the treatment plan for the patient to be tested and the target standard treatment plan. If the similarity is greater than the preset similarity, the target disease corresponding to the target standard treatment plan is compared.
- the species is determined to be the disease species of the patient to be tested.
- the treatment plan of the patient to be tested includes: treatment item A, treatment item B, treatment item C, treatment item D
- the target standard treatment plan corresponding to appendicitis includes: treatment item A, treatment item B, treatment item C, treatment item D
- the terminal determines that the similarity between the treatment plan for the patient to be tested and the target standard treatment plan is greater than the preset threshold, and determines that the disease type of the patient to be tested is appendicitis.
- the terminal obtains the target standard treatment plan with the highest similarity among the at least one target standard treatment plan and the treatment plan for the patient to be detected, and determines the target disease type corresponding to the target standard treatment plan with the highest similarity as the disease to be detected by the patient Diseases.
- the specific calculation method of the similarity between the treatment plan of the patient to be tested and the target standard treatment plan may be that the terminal obtains the first number of the same treatment items in the treatment plan for the patient to be tested and the target standard treatment plan; And calculate the ratio between the first number and the number of treatment items in the treatment plan for the patient to be tested, and the terminal determines the calculated ratio as the similarity between the treatment plan for the patient to be tested and the target standard treatment plan.
- the terminal acquires at least one treatment plan of at least one sample patient in a preset area, where the sample patient has the same target disease type, and determines a clinical path corresponding to the target disease type from the at least one treatment plan The matched first treatment plan; if the utilization rate of the first treatment plan is greater than the preset threshold, the terminal determines the first treatment plan as the target standard treatment plan, and determines the pending treatment in the preset area according to the target standard treatment plan Detect the disease type of the patient.
- FIG. 2 is a schematic flowchart of another method for determining a disease type based on sample processing in an embodiment of the present application. As shown in the figure, the flow of the method for determining a disease based on sample processing in this embodiment may include:
- the terminal acquires at least one treatment plan of at least one sample patient in a preset area, where the sample patients have the same target disease type.
- the preset area may be an area composed of one or more cities, districts, or counties, and the sample patients have the same target disease, and the target disease may be single diseases such as appendicitis, cholecystitis, and gallstone Species.
- the treatment plan is a collection of treatment items received by the sample patient, where the treatment items may include blood drawing, CT, taking medicine, hospitalization, etc.
- the terminal may also select a sample patient from patients with target diseases in the preset area according to a preset screening condition, where,
- the preset screening conditions may be the same age group, the same gender, the same historical illness, etc.
- the terminal can divide the patient's age group into 4 age groups, including infants (0-3 years old), children (3-12 years old), middle-aged and young people (13-60 years old), In the elderly (over 60 years old), the terminal determines the patients in any age group as the sample patients.
- the terminal can divide the patient's historical condition into diabetes, hypertension, heart disease, and hepatitis B.
- the terminal determines the patient with any historical condition as a sample patient.
- the terminal determines a first treatment plan matching the clinical path corresponding to the target disease type from at least one treatment plan.
- the terminal after acquiring at least one treatment plan of at least one sample patient in a preset area, the terminal determines a first treatment plan matching the clinical path corresponding to the target disease type from the at least one treatment plan.
- the specific determination method of the first treatment plan may be to separately calculate the similarity of the clinical path corresponding to each target treatment type in each of the at least one treatment plan, and to compare the at least one treatment plan corresponding to the target disease type The treatment plan with the highest clinical path similarity is determined as the first treatment plan.
- the similarity is determined by the number of the same treatment items in the clinical path corresponding to the target disease type of the treatment plan, and the terminal determines the treatment plan with the highest similarity of the clinical path corresponding to the target disease type in at least one treatment plan as the first One treatment plan.
- the terminal calculates the utilization rate of the first treatment plan according to the number of first sample patients corresponding to the first treatment plan.
- the specific calculation method of the usage rate of the first treatment plan may be that the terminal obtains the number of patients of the first sample corresponding to the first treatment plan, and the terminal calculates the number of patients of the first sample and the preset area Within the ratio of the number of at least one sample patient, the terminal uses the calculated ratio as the usage rate of the first treatment plan, where the first sample patient is at least one sample patient treated with the first treatment plan. For example, if the number of first sample patients is 100 and the number of at least one sample patient in the preset area is 500, it is determined that the utilization rate of the first treatment plan is 20%.
- the terminal obtains a second treatment plan with the highest utilization rate among at least one treatment plan.
- the terminal after acquiring the utilization rate of the first treatment plan, the terminal will detect whether the first treatment plan is greater than a preset threshold, and if the utilization rate of the first treatment plan is less than or equal to the preset threshold, the terminal will also acquire At least one second treatment plan with the highest usage rate among the treatment plans, wherein the specific acquisition method of the usage rate of the second treatment plan may be that the terminal acquires the number of target sample patients corresponding to the target treatment plan, where the target sample patients are at least For any one of the sample patients, the terminal calculates the ratio of the number of target sample patients to the number of at least one sample patient in the preset area, and the terminal uses the calculated ratio as the utilization rate of the target treatment plan.
- the terminal After the terminal calculates the usage rate of each treatment plan in at least one treatment plan, the treatment plan with the highest usage rate in at least one treatment plan is determined as the second treatment plan. Wherein, if the utilization rate of the first treatment plan is the highest, the first treatment plan is the same as the second treatment plan, the terminal determines the first treatment plan as the target standard treatment plan, and executes step S206.
- the terminal detects the difference between the usage rate of the second treatment plan and the usage rate of the first treatment plan, and determines the target standard treatment plan according to the difference. .
- the terminal after acquiring the usage rates of the first treatment plan and the second treatment plan, the terminal will detect the difference between the usage rate of the second treatment plan and the usage rate of the first treatment plan.
- the terminal determines the second treatment plan as the target standard treatment plan.
- the usage rate of the first treatment plan is 10%
- the usage rate of the second treatment plan is 80%
- the preset difference is 30%
- the difference between the usage rate of the second treatment plan and the usage rate of the first treatment plan If the value is greater than the preset difference, the terminal determines the second treatment plan as the target standard treatment plan.
- the first treatment plan is determined as the target standard treatment plan.
- the usage rate of the first treatment plan is 40%
- the usage rate of the second treatment plan is 42%
- the preset difference is 30%
- the difference between the usage rate of the second treatment plan and the usage rate of the first treatment plan If the value is less than the preset difference, the terminal determines the first treatment plan as the target standard treatment plan.
- the terminal may also obtain the first treatment cost corresponding to the first treatment plan and the second treatment cost corresponding to the second treatment plan, and determine the corresponding amount of the first treatment plan according to the correspondence between the cost and the weighting coefficient
- the first weighting coefficient and the second weighting coefficient corresponding to the second treatment plan may have different correspondences between the treatment cost and the weighting coefficient for different target diseases. For example, if the target disease is appendicitis, the cost and the weighting coefficient The corresponding relationship can be shown in Table 2.
- the terminal may use the first weighting coefficient to weight the usage rate of the first treatment plan to obtain the first weighted usage rate;
- the usage rate is weighted to obtain the second weighted usage rate.
- the terminal calculates the difference between the second weighted usage rate and the first weighted usage rate. If the calculated difference is greater than the preset difference, the second treatment plan is determined as the target standard treatment plan; if the calculated difference is less than or If it is equal to the preset difference, the first treatment plan is determined as the target standard treatment plan.
- the terminal determines the disease type of the patient to be detected in the preset area according to the target standard treatment plan.
- the patient to be tested may be a patient undergoing treatment in a preset area.
- the disease type of the patient to be tested in the preset area will be determined according to the target standard treatment plan.
- the terminal obtains the treatment plan for the patient to be tested, and detects the similarity between the treatment plan for the patient to be tested and the target standard treatment plan. If the similarity is greater than the preset similarity, the target disease corresponding to the target standard treatment plan is compared.
- the species is determined to be the disease species of the patient to be tested.
- the terminal obtains the target standard treatment plan with the highest similarity among the at least one target standard treatment plan and the treatment plan for the patient to be detected, and determines the target disease type corresponding to the target standard treatment plan with the highest similarity as the disease to be detected by the patient Diseases.
- the target standard treatment plan corresponding to appendicitis is treatment plan 1
- the target standard treatment plan corresponding to cholecystitis is treatment plan 2
- the target standard treatment plan corresponding to gallstones is treatment plan 3
- the terminal detects a treatment plan for the patient to be tested The highest degree of similarity with treatment option 1, the terminal determines the disease type of the patient to be tested as appendicitis.
- the terminal can detect the treatment items received by the patient to be tested in real time during the patient's treatment, and each time the patient to be tested completes a new treatment item, the terminal calculates the treatment plan composed of each item and each target standard treatment The similarity of the plan, and display the patients' possible diseases according to the similarity ranking order, so that the patient can understand the changes in his condition in real time.
- the terminal will compare each target standard treatment plan with The target disease type corresponding to the target standard treatment program with the highest similarity of the treatment plan of the patient to be tested is determined as the disease type of the patient to be tested. Further, after determining the disease type of the patient, the terminal can provide a corresponding basis for the medical reimbursement of the patient.
- the specific calculation method of the similarity between the treatment plan of the patient to be tested and the target standard treatment plan may be that the terminal obtains the first number of the same treatment items in the treatment plan for the patient to be tested and the target standard treatment plan, And calculate the ratio between the first number and the number of treatment items in the treatment plan for the patient to be tested, and the terminal determines the calculated ratio as the similarity between the treatment plan for the patient to be tested and the target standard treatment plan.
- the terminal acquires at least one treatment plan of at least one sample patient in a preset area, where the sample patient has the same target disease type, and determines a clinical path corresponding to the target disease type from the at least one treatment plan Match the first treatment plan.
- the terminal calculates the difference between the usage rate of the second treatment plan with the highest usage rate and the usage rate of the first treatment plan, and determines the target standard treatment plan according to the difference , The terminal determines the disease type of the patient according to the target standard treatment plan, by establishing different target standard treatment plans for different regions, and then finding the target standard treatment plan that matches the patient's actual treatment plan to determine the patient's disease type, you can Improve the accuracy of the determination of the patient's disease.
- FIG. 3 is a schematic structural diagram of a sample processing-based disease determination device provided by the present application.
- the sample processing-based disease determination device 30 may include: an acquisition module 301, a determination module 302, and a calculation module 303.
- the obtaining module 301 is configured to obtain at least one treatment plan of at least one sample patient in a preset area, where the sample patients have the same target disease type;
- the determination module 302 is configured to determine a first treatment plan matching the clinical path corresponding to the target disease type from the at least one treatment plan;
- the calculation module 303 is configured to calculate the utilization rate of the first treatment plan according to the number of first sample patients corresponding to the first treatment plan, and the first sample patient is treated by using the first treatment plan At least one sample patient;
- the determining module 302 is further configured to determine the first treatment plan as a target standard treatment plan if the utilization rate of the first treatment plan is greater than a preset threshold, and the target standard treatment plan is Set a standard treatment plan corresponding to the area and the target disease, and the target standard treatment plan includes at least one standard treatment item for treating the target disease in the preset area;
- the determination module 302 is further configured to determine the disease type of the patient to be detected in the preset area according to the target standard treatment plan.
- the treatment plan includes at least one treatment item
- the calculation module 303 is further configured to separately calculate the similarity between each treatment plan of the at least one treatment plan and the clinical path corresponding to the target disease type. The number of the same treatment items in the corresponding clinical path is determined;
- the determination module 302 is further configured to determine the treatment plan with the highest degree of similarity of the clinical path corresponding to the target disease among the at least one treatment plan as the first treatment plan.
- the device further includes a detection module 304;
- the obtaining module 301 is further used to obtain the length of hospitalization of at least one patient with a target disease in a preset area;
- the detection module 304 is configured to detect whether the variance of the hospitalization length of the at least one patient is less than the preset variance
- the determination module 302 is also used to determine at least one patient with the target disease in the preset area as a sample patient if it is.
- the detection module is further configured to screen patients with a target disease in a preset area according to preset screening conditions, and the screening conditions include the same gender, the same age group, or The same medical history;
- the determining module is further configured to determine, as a sample patient, a patient suffering from the target disease that satisfies the screening condition in the preset area.
- the obtaining module 301 is further configured to obtain the number of patients in the first sample corresponding to the first treatment plan;
- the calculation module 303 is further configured to calculate the ratio of the number of patients in the first sample to the number of patients in the at least one sample;
- the determining module 302 is further configured to determine the ratio as the utilization rate of the first treatment plan.
- the obtaining module 301 is further configured to obtain a second treatment plan with the highest utilization rate among the at least one treatment plan if the utilization rate of the first treatment plan is less than or equal to a preset threshold ;
- the detection module 304 is further configured to detect the difference between the usage rate of the second treatment plan and the usage rate of the first treatment plan;
- the determining module 302 is further configured to determine the second treatment plan as the target standard treatment plan if the difference is greater than a preset difference;
- the determining module 302 is further configured to determine the first treatment plan as the target standard treatment plan if the difference is less than or equal to a preset difference.
- the acquisition module is further configured to acquire a second treatment plan with the highest usage rate among the at least one treatment plan if the usage rate of the first treatment plan is less than or equal to a preset threshold;
- the obtaining module is further configured to obtain a first treatment cost corresponding to the first treatment plan and a second treatment cost corresponding to the second treatment plan;
- the determining module is further configured to determine a first weighting coefficient corresponding to the first treatment plan and a second weighting coefficient corresponding to the second treatment plan according to the correspondence between the cost and the weighting coefficient;
- the calculation module is further configured to perform weighted processing on the utilization rate of the first treatment plan using the first weighting coefficient to obtain a first weighted utilization rate
- the calculation module is further configured to use the second weighting coefficient to perform weighted processing on the usage rate of the second treatment plan to obtain a second weighted usage rate;
- the calculation module is further configured to calculate the difference between the second weighted usage rate and the first weighted usage rate
- the determining module is further configured to determine the second treatment plan as the target standard treatment plan if the difference is greater than a preset difference
- the determining module is further configured to determine the first treatment plan as the target standard treatment plan if the difference is less than or equal to the preset difference.
- the obtaining module 301 is further used to obtain a treatment plan for the patient to be detected;
- the detection module 304 is also used to detect the similarity between the treatment plan for the patient to be detected and the target standard treatment plan;
- the determining module 302 is further configured to determine the target disease type corresponding to the target standard treatment plan as the disease type of the patient to be detected if the similarity is greater than the preset similarity.
- the detection module is specifically used to:
- the obtaining module 301 is further configured to obtain the first number of the same treatment items in the treatment plan for the patient to be detected and the target standard treatment plan;
- the calculation module 303 is further configured to calculate a ratio of the first number to the number of treatment items in the treatment plan for the patient to be detected;
- the determination module 302 is further configured to determine the ratio as the similarity between the treatment plan for the patient to be detected and the target standard treatment plan.
- the obtaining module 301 obtains at least one treatment plan of at least one sample patient in a preset area, and the sample patient suffers from the same target disease type; the determination module 302 determines from the at least one treatment plan A first treatment plan matching the clinical path corresponding to the target disease type; the calculation module 303 calculates the utilization rate of the first treatment plan according to the number of first sample patients corresponding to the first treatment plan; if the first If the usage rate of a treatment plan is greater than a preset threshold, the determination module 302 determines the first treatment plan as the target standard treatment plan, and the determination module 302 determines the patient to be tested in the preset area according to the target standard treatment plan The disease.
- the terminal includes: at least one processor 401, input device 403, output device 404, memory 405, and at least one communication bus 402.
- the communication bus 402 is used to implement connection communication between these components.
- the input device 403 may be a control panel or a microphone
- the output device 404 may be a display screen.
- the memory 405 may be a high-speed RAM memory or a non-volatile memory (non-volatile memory), for example, at least one magnetic disk memory.
- the memory 405 may optionally be at least one storage device located away from the foregoing processor 401.
- the processor 401 may be combined with the apparatus described in FIG. 3, a group of program codes is stored in the memory 405, and the processor 401, the input device 403, and the output device 404 call the program codes stored in the memory 405 to perform the following operations:
- the processor 401 is configured to acquire at least one treatment plan of at least one sample patient in a preset area, where the sample patients have the same target disease type;
- the processor 401 is configured to determine a first treatment plan matching the clinical path corresponding to the target disease type from the at least one treatment plan;
- the processor 401 is configured to calculate the utilization rate of the first treatment plan according to the number of first sample patients corresponding to the first treatment plan, and the first sample patient is treated by using the first treatment plan At least one sample patient;
- the processor 401 is configured to determine the first treatment plan as a target standard treatment plan if the utilization rate of the first treatment plan is greater than a preset threshold, and the target standard treatment plan is the same as the preset area and all A standard treatment plan corresponding to the target disease type, where the target standard treatment plan includes at least one standard treatment item for treating the target disease type in the preset area;
- the processor 401 is configured to determine the disease type of the patient to be detected in the preset area according to the target standard treatment plan.
- the treatment plan includes at least one treatment item
- the processor 401 is specifically configured to:
- the similarity is determined by the same treatment in the clinical path corresponding to the target disease
- the number of projects is determined
- the treatment plan with the highest similarity in the clinical path corresponding to the target disease among the at least one treatment plan is determined as the first treatment plan.
- the processor 401 is specifically used to:
- At least one patient with the target disease in the preset area is determined as the sample patient.
- the processor 401 is specifically used to:
- Screen patients with a target disease in a preset area according to preset screening conditions, where the screening conditions include the same gender, the same age group, or the same medical history;
- a patient with the target disease that meets the screening conditions in the preset area is determined as a sample patient.
- the processor 401 is specifically used to:
- the ratio is determined as the utilization rate of the first treatment regimen.
- the processor 401 is specifically used to:
- the utilization rate of the first treatment plan is less than or equal to a preset threshold, obtain a second treatment plan with the highest utilization rate among the at least one treatment plan;
- the second treatment plan is determined to be the target standard treatment plan
- the first treatment plan is determined as the target standard treatment plan.
- the processor 401 is specifically used to:
- the utilization rate of the first treatment plan is less than or equal to a preset threshold, obtain a second treatment plan with the highest utilization rate among the at least one treatment plan;
- the second treatment plan is determined to be the target standard treatment plan
- the first treatment plan is determined to be the target standard treatment plan.
- the processor 401 is specifically used to:
- the target disease type corresponding to the target standard treatment plan is determined as the disease type of the patient to be tested.
- the processor 401 is specifically used to:
- the ratio is determined as the similarity of the treatment plan for the patient to be tested and the target standard treatment plan.
- the processor 401 acquires at least one treatment plan of at least one sample patient in a preset area, and the sample patient has the same target disease type, and the processor 401 determines from the at least one treatment plan A first treatment plan matching the clinical path corresponding to the target disease type; and calculating the utilization rate of the first treatment plan according to the number of first sample patients corresponding to the first treatment plan; if the first treatment If the usage rate of the plan is greater than the preset threshold, the processor 401 determines the first treatment plan as the target standard treatment plan, and the processor 401 determines the patients to be detected in the preset area according to the target standard treatment plan Disease.
- the modules described in the embodiments of the present application may be implemented by a general-purpose integrated circuit, such as a CPU (Central Processing Unit, central processing unit), or an ASIC (Application Specific Integrated Circuit).
- a CPU Central Processing Unit, central processing unit
- ASIC Application Specific Integrated Circuit
- the so-called processor 401 may be a central processing module (Central Processing Unit, CPU), and the processor may also be other general-purpose processors, digital signal processors (Digital Signal Processor, DSP) , Application Specific Integrated Circuit (Application Specific Integrated Circuit, ASIC), ready-made programmable gate array (Field-Programmable Gate Array, FPGA) or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc.
- the general-purpose processor may be a microprocessor or the processor may be any conventional processor or the like.
- the bus 402 may be an industry standard architecture (Industry Standard Architecture, ISA) bus, an external device interconnection (Peripheral Component, PCI) bus, or an extended industry standard architecture (Extended Industry Standard Architecture, EISA) bus, etc.
- ISA Industry Standard Architecture
- PCI Peripheral Component
- EISA Extended Industry Standard Architecture
- the bus 402 may be divided into Address bus, data bus, control bus, etc., for ease of representation, Figure 4 is only represented by a thick line, but does not mean that there is only one bus or one type of bus.
- the computer-readable storage medium may be a magnetic disk, an optical disk, a read-only memory (Read-Only Memory, ROM) or a random access memory (Random Access Memory, RAM), etc.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (20)
- 一种基于样本处理的病种确定方法,其特征在于,包括:获取预设区域内至少一个样本患者的至少一个治疗方案,所述样本患者患有相同的目标病种;从所述至少一个治疗方案中确定与所述目标病种对应的临床路径相匹配的第一治疗方案;根据所述第一治疗方案对应的第一样本患者的数量计算所述第一治疗方案的使用率,所述第一样本患者为采用所述第一治疗方案进行治疗的至少一个样本患者;若所述第一治疗方案的使用率大于预设阈值,则将所述第一治疗方案确定为目标标准治疗方案,所述目标标准治疗方案为与所述预设区域和所述目标病种对应的标准治疗方案,所述目标标准治疗方案中包括至少一个用于在所述预设区域内对所述目标病种进行治疗的标准治疗项目;根据所述目标标准治疗方案确定所述预设区域内的待检测患者所患的病种。
- 根据权利要求1所述的方法,其特征在于,所述治疗方案包括至少一个治疗项目,所述从所述至少一个治疗方案中确定与所述目标病种对应的临床路径相匹配的第一治疗方案,包括:分别计算所述至少一个治疗方案中每个治疗方案与所述目标病种对应的临床路径的相似度,所述相似度由所述治疗方案与所述目标病种对应的临床路径中相同的治疗项目的数量所确定;将所述至少一个治疗方案中与所述目标病种对应的临床路径的相似度最高的治疗方案确定为第一治疗方案。
- 根据权利要求1所述的方法,其特征在于,所述获取预设区域内至少一个样本患者的至少一个治疗方案之前,所述方法还包括:获取预设区域内患有目标病种的至少一个患者的住院时长;检测所述至少一个患者的住院时长的方差是否小于预设方差;若是,则将所述预设区域内患有目标病种的至少一个患者确定为样本患者。
- 根据权利要求1所述的方法,其特征在于,所述获取预设区域内至少一个样本患者的至少一个治疗方案之前,所述方法还包括:按照预设的筛选条件对预设区域内患有目标病种的患者进行筛选,所述筛选条件包括相同的性别、相同的年龄段或相同的病史;将所述预设区域内满足所述筛选条件的患有所述目标病种的患者确定为样本患者。
- 根据权利要求1所述的方法,其特征在于,所述根据所述第一治疗方案对应的第一样本患者的数量计算所述第一治疗方案的使用率,包括:获取所述第一治疗方案对应的第一样本患者的数量;计算所述第一样本患者的数量与所述至少一个样本患者的数量的比值;将所述比值确定为所述第一治疗方案的使用率。
- 根据权利要求1-5任一项所述的方法,其特征在于,所述方法还包括:若所述第一治疗方案的使用率小于或等于预设阈值,则获取所述至少一个治疗方案中使用率最高的第二治疗方案;检测所述第二治疗方案的使用率和所述第一治疗方案的使用率的差值;若所述差值大于预设差值,则将所述第二治疗方案确定为所述目标标准治疗方案;若所述差值小于或等于预设差值,则将所述第一治疗方案确定为所述目标标准治疗方案。
- 根据权利要求1-5任一项所述的方法,其特征在于,所述方法还包括:若所述第一治疗方案的使用率小于或等于预设阈值,则获取所述至少一个治疗方案中使用率最高的第二治疗方案;获取所述第一治疗方案对应的第一治疗费用以及所述第二治疗方案对应的第二治疗费用;根据费用与加权系数的对应关系确定所述第一治疗方案对应的第一加权系数,以及所述第二治疗方案对应的第二加权系数;采用所述第一加权系数对所述第一治疗方案的使用率进行加权处理,得到第一加权使用率,并采用所述第二加权系数对所述第二治疗方案的使用率进行加权处理,得到第二加权使用率;计算所述第二加权使用率与所述第一加权使用率的差值;若所述差值大于预设差值,则将所述第二治疗方案确定为所述目标标准治疗方案;若所述差值小于或等于所述预设差值,则将所述第一治疗方案确定为所述目标标准治疗方案。
- 根据权利要求1所述的方法,其特征在于,所述根据所述目标标准治疗方案确定所述预设区域内的待检测患者所患的病种,包括:获取针对待检测患者的治疗方案;检测所述针对待检测患者的治疗方案与所述目标标准治疗方案的相似度;若所述相似度大于预设相似度,则将所述目标标准治疗方案对应的目标病种确定为所述待检测患者所患的病种。
- 根据权利要求8所述的方法,其特征在于,所述检测所述针对待检测患者的治疗方案与所述标准治疗方案的相似度,包括:获取所述针对待检测患者的治疗方案与所述目标标准治疗方案中相同的治疗项目的第一数量;计算所述第一数量与所述针对待检测患者的治疗方案中治疗项目的数量的比值;将所述比值确定为所述针对待检测患者的治疗方案与所述目标标准治疗方案的相似度。
- 一种基于样本处理的病种确定装置,其特征在于,所述装置包括:获取模块,用于获取预设区域内至少一个样本患者的至少一个治疗方案,所述样本患者患有相同的目标病种;确定模块,用于从所述至少一个治疗方案中确定与所述目标病种对应的临床路径相匹配的第一治疗方案;计算模块,用于根据所述第一治疗方案对应的第一样本患者的数量计算所述第一治疗 方案的使用率,所述第一样本患者为采用所述第一治疗方案进行治疗的至少一个样本患者;所述确定模块,还用于若所述第一治疗方案的使用率大于预设阈值,则将所述第一治疗方案确定为目标标准治疗方案,所述目标标准治疗方案为与所述预设区域和所述目标病种对应的标准治疗方案,所述目标标准治疗方案中包括至少一个用于在所述预设区域内对所述目标病种进行治疗的标准治疗项目;所述确定模块,还用于根据所述目标标准治疗方案确定所述预设区域内的待检测患者所患的病种。
- 根据权利要求10所述的装置,其特征在于,所述治疗方案包括至少一个治疗项目,所述计算模块,还用于分别计算所述至少一个治疗方案中每个治疗方案与所述目标病种对应的临床路径的相似度,所述相似度由所述治疗方案与所述目标病种对应的临床路径中相同的治疗项目的数量所确定;所述确定模块,还用于将所述至少一个治疗方案中与所述目标病种对应的临床路径的相似度最高的治疗方案确定为第一治疗方案。
- 根据权利要求10所述的装置,其特征在于,所述装置还包括检测模块;所述获取模块,还用于获取预设区域内患有目标病种的至少一个患者的住院时长;所述检测模块,用于检测所述至少一个患者的住院时长的方差是否小于预设方差;所述确定模块,还用于若是,则将所述预设区域内患有目标病种的至少一个患者确定为样本患者。
- 根据权利要求10所述的装置,其特征在于,所述检测模块,还用于按照预设的筛选条件对预设区域内患有目标病种的患者进行筛选,所述筛选条件包括相同的性别、相同的年龄段或相同的病史;所述确定模块,还用于将所述预设区域内满足所述筛选条件的患有所述目标病种的患者确定为样本患者。
- 根据权利要求10所述的装置,其特征在于,所述获取模块,还用于获取第一治疗方案对应的第一样本患者的数量;所述计算模块,还用于计算所述第一样本患者的数量与所述至少一个样本患者的数量的比值;所述确定模块,还用于将所述比值确定为所述第一治疗方案的使用率。
- 根据权利要求10-14任一项所述的装置,其特征在于,所述获取模块,还用于若所述第一治疗方案的使用率小于或等于预设阈值,则获取所述至少一个治疗方案中使用率最高的第二治疗方案;所述检测模块,还用于检测所述第二治疗方案的使用率和所述第一治疗方案的使用率的差值;所述确定模块,还用于若所述差值大于预设差值,则将所述第二治疗方案确定为所述目标标准治疗方案;所述确定模块,还用于若所述差值小于或等于预设差值,则将所述第一治疗方案确定为所述目标标准治疗方案。
- 根据权利要求10-14任一项所述的装置,其特征在于,所述获取模块,还用于若所述第一治疗方案的使用率小于或等于预设阈值,则获取所述至少一个治疗方案中使用率最高的第二治疗方案;所述获取模块,还用于获取所述第一治疗方案对应的第一治疗费用以及所述第二治疗方案对应的第二治疗费用;所述确定模块,还用于根据费用与加权系数的对应关系确定所述第一治疗方案对应的第一加权系数,以及所述第二治疗方案对应的第二加权系数;所述计算模块,还用于采用所述第一加权系数对所述第一治疗方案的使用率进行加权处理,得到第一加权使用率,所述计算模块,还用于采用所述第二加权系数对所述第二治疗方案的使用率进行加权处理,得到第二加权使用率;所述计算模块,还用于计算所述第二加权使用率与所述第一加权使用率的差值;所述确定模块,还用于若所述差值大于预设差值,则将所述第二治疗方案确定为所述目标标准治疗方案;所述确定模块,还用于若所述差值小于或等于所述预设差值,则将所述第一治疗方案确定为所述目标标准治疗方案。
- 根据权利要求10所述的装置,其特征在于,所述获取模块,还用于获取针对待检测患者的治疗方案;所述检测模块,还用于检测所述针对待检测患者的治疗方案与所述目标标准治疗方案的相似度;所述确定模块,还用于若所述相似度大于预设相似度,则将所述目标标准治疗方案对应的目标病种确定为所述待检测患者所患病种。
- 根据权利要求17所述的装置,其特征在于,所述获取模块,还用于获取所述针对待检测患者的治疗方案与所述目标标准治疗方案中相同的治疗项目的第一数量;所述计算模块,还用于计算所述第一数量与所述针对待检测患者的治疗方案中治疗项目的数量的比值;所述确定模块,还用于将所述比值确定为所述针对待检测患者的治疗方案与所述目标标准治疗方案的相似度。
- 一种终端,其特征在于,所述终端包括处理器、输入设备、输出设备和存储器,所述处理器、输入设备、输出设备和存储器相互连接,其中,所述存储器用于存储计算机程序,所述计算机程序包括程序指令,所述处理器被配置用于调用所述程序指令,执行如权利要求1-9任一项所述的方法。
- 一种计算机可读存储介质,其特征在于,所述计算机可读存储介质存储有计算机程序,所述计算机程序包括程序指令,所述程序指令当被处理器执行时使所述处理器执行如权利要求1-9任一项所述的方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811265501.7 | 2018-10-27 | ||
CN201811265501.7A CN109559819B (zh) | 2018-10-27 | 2018-10-27 | 基于样本处理的病种确定方法、装置及终端 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020082806A1 true WO2020082806A1 (zh) | 2020-04-30 |
Family
ID=65865516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2019/095049 WO2020082806A1 (zh) | 2018-10-27 | 2019-07-08 | 基于样本处理的病种确定方法、装置及终端 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN109559819B (zh) |
WO (1) | WO2020082806A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109559819B (zh) * | 2018-10-27 | 2024-06-18 | 平安医疗健康管理股份有限公司 | 基于样本处理的病种确定方法、装置及终端 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105912881A (zh) * | 2016-06-14 | 2016-08-31 | 华南师范大学 | 基于大数据知识库的个性化治疗方案推荐系统 |
WO2017062308A1 (en) * | 2015-10-06 | 2017-04-13 | General Electric Company | System and method for clinical decision support |
CN108109692A (zh) * | 2017-11-08 | 2018-06-01 | 北京无极慧通科技有限公司 | 一种治疗方案的选择方法和系统 |
CN108242266A (zh) * | 2018-01-22 | 2018-07-03 | 北京颐圣智能科技有限公司 | 辅助诊断装置和方法 |
CN109545370A (zh) * | 2018-10-27 | 2019-03-29 | 平安医疗健康管理股份有限公司 | 基于样本处理的病种确定方法、装置及终端 |
CN109559819A (zh) * | 2018-10-27 | 2019-04-02 | 平安医疗健康管理股份有限公司 | 基于样本处理的病种确定方法、装置及终端 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4775358B2 (ja) * | 2007-10-19 | 2011-09-21 | 株式会社日立製作所 | クリニカルパス運用支援情報システム |
EP3054413A4 (en) * | 2013-10-03 | 2016-08-10 | Fujifilm Corp | CLINICAL ROUTING MANAGEMENT DEVICE |
CN106169165B (zh) * | 2015-05-20 | 2020-06-16 | 詹宇 | 面向诊疗数据的症状层次关联及预测方法 |
CN106202942A (zh) * | 2016-07-14 | 2016-12-07 | 深圳市前海安测信息技术有限公司 | 临床路径自动生成系统和方法 |
CN107038344A (zh) * | 2017-04-24 | 2017-08-11 | 大连诺道认知医学技术有限公司 | 一种病种实际临床路径与标准临床路径比较方法及装置 |
CN108538349A (zh) * | 2018-03-28 | 2018-09-14 | 深圳市前海安测信息技术有限公司 | 基于临床路径偏差分析的医院临床路径调整系统及方法 |
-
2018
- 2018-10-27 CN CN201811265501.7A patent/CN109559819B/zh active Active
-
2019
- 2019-07-08 WO PCT/CN2019/095049 patent/WO2020082806A1/zh active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017062308A1 (en) * | 2015-10-06 | 2017-04-13 | General Electric Company | System and method for clinical decision support |
CN105912881A (zh) * | 2016-06-14 | 2016-08-31 | 华南师范大学 | 基于大数据知识库的个性化治疗方案推荐系统 |
CN108109692A (zh) * | 2017-11-08 | 2018-06-01 | 北京无极慧通科技有限公司 | 一种治疗方案的选择方法和系统 |
CN108242266A (zh) * | 2018-01-22 | 2018-07-03 | 北京颐圣智能科技有限公司 | 辅助诊断装置和方法 |
CN109545370A (zh) * | 2018-10-27 | 2019-03-29 | 平安医疗健康管理股份有限公司 | 基于样本处理的病种确定方法、装置及终端 |
CN109559819A (zh) * | 2018-10-27 | 2019-04-02 | 平安医疗健康管理股份有限公司 | 基于样本处理的病种确定方法、装置及终端 |
Also Published As
Publication number | Publication date |
---|---|
CN109559819A (zh) | 2019-04-02 |
CN109559819B (zh) | 2024-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10949968B2 (en) | Systems and methods for detecting an indication of a visual finding type in an anatomical image | |
Sutherland et al. | AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions | |
US11923094B2 (en) | Monitoring predictive models | |
WO2019215604A1 (en) | Systems and methods for detecting an indication of a visual finding type in an anatomical image | |
WO2020181807A1 (zh) | 健康提醒方法、装置、计算机设备及存储介质 | |
TW201402059A (zh) | 健康狀態判定方法及健康狀態判定系統 | |
WO2020119098A1 (zh) | 一种健康评估方法、装置及计算机可读存储介质 | |
CN109545387B (zh) | 一种基于神经网络的异常病例识别方法及计算设备 | |
WO2021073263A1 (zh) | 一种患病风险的预测方法及装置 | |
CN109509104B (zh) | 基于人脸识别的身份认证方法、装置、服务器及介质 | |
CN109545370B (zh) | 基于样本处理的病种确定方法、装置及终端 | |
CN111883222B (zh) | 文本数据的错误检测方法、装置、终端设备及存储介质 | |
Holko et al. | Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012–2014: an analysis of nationwide databases | |
WO2020082806A1 (zh) | 基于样本处理的病种确定方法、装置及终端 | |
CN109545319B (zh) | 基于知识关系分析的处方告警方法及终端设备 | |
WO2020082796A1 (zh) | 基于数据分析的就诊信息处理方法、装置、设备及介质 | |
CN115905960A (zh) | 一种基于心室辅助装置的不良事件检测方法及装置 | |
WO2019130495A1 (ja) | コンピュータシステム、薬提案方法及びプログラム | |
WO2021184579A1 (zh) | 多解决方案的智能选择方法、装置、计算机设备及存储介质 | |
CN109559820B (zh) | 基于数据处理的冠心病资质认证方法、设备及服务器 | |
CN113870973A (zh) | 基于人工智能的信息输出方法、装置、计算机设备及介质 | |
CN109544378B (zh) | 一种肺源性心脏病资质认证方法、设备及服务器 | |
CN112447302B (zh) | 身高增长速度评价方法及终端设备 | |
CN106228174B (zh) | 带状疱疹判断方法及装置 | |
CN115101192B (zh) | 基于方剂的症状推荐方法、装置、设备及存储介质 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19874977 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19874977 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19874977 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22/12/2021) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19874977 Country of ref document: EP Kind code of ref document: A1 |